252 results
Page 4 of 13
424B5
x1z3hydmqve ohvpsa
29 Jan 21
Prospectus supplement for primary offering
5:15pm
8-K
EX-99.1
5k6 giy0533fy85pevd
28 Jan 21
Updated Summary Business Information
4:26pm
424B5
6enxosby
28 Jan 21
Prospectus supplement for primary offering
4:08pm
8-K
EX-99.1
l6q9 l9xe
28 Jan 21
Adamis Pharmaceuticals and Human Immune Monitoring Center at Stanford University Announce Preliminary Tempol Data in Cells from COVID-19 Patients
9:25am
8-K
66sy6m5q8fet g5q2p9
28 Jan 21
Adamis Pharmaceuticals and Human Immune Monitoring Center at Stanford University Announce Preliminary Tempol Data in Cells from COVID-19 Patients
9:25am
8-K
EX-99.1
5du6ak87fn fp1
22 Jan 21
SYMJEPI Products Now Available in the Walgreens Prescription Savings Club, with the Lowest Prices for Epinephrine Products
8:32am
8-K
hx13o1slhaqg93jgp5zy
22 Jan 21
SYMJEPI Products Now Available in the Walgreens Prescription Savings Club, with the Lowest Prices for Epinephrine Products
8:32am
8-K
EX-99.1
mb8lzce
20 Jan 21
Adamis Pharmaceuticals Announces IND Submission to FDA for Tempol for the Treatment of COVID-19
5:06pm
8-K
93i8a9r ybs70qu8y
20 Jan 21
Adamis Pharmaceuticals Announces IND Submission to FDA for Tempol for the Treatment of COVID-19
5:06pm
8-K
ar16w3jx 9bd2cnn30p5
1 Dec 20
Adamis Pharmaceuticals Describes Planned Response to ZIMHI Complete Response Letter
5:04pm
8-K
EX-99.1
9wem5t7r
1 Dec 20
Adamis Pharmaceuticals Describes Planned Response to ZIMHI Complete Response Letter
5:04pm
8-K
9sriz4itz9
16 Nov 20
Adamis Pharmaceuticals Receives a Complete Response Letter from the FDA Regarding ZIMHI
5:23pm
8-K
EX-99.1
xmahq i3k9ql859r
16 Nov 20
Adamis Pharmaceuticals Receives a Complete Response Letter from the FDA Regarding ZIMHI
5:23pm
8-K
EX-99.1
s7dddp
9 Nov 20
Adamis Pharmaceuticals Announces Third Quarter 2020 Financial Results and Business Update
4:24pm
8-K
EX-99.2
y56lizcb5a8k
5 Oct 20
Report of Independent Registered Public Accounting Firm
5:25pm
424B5
xhq8t7v9uz1l7b
21 Sep 20
Prospectus supplement for primary offering
6:03am
424B5
5rw5gf lj3r0xr
17 Sep 20
Prospectus supplement for primary offering
4:22pm
8-K
EX-99.1
7vi4 cx8y
18 Aug 20
Adamis Pharmaceuticals Announces Second Quarter 2020 Financial Results and Business Update
12:00am